{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:10:14Z","timestamp":1794852614554,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA021525"],"award-info":[{"award-number":["R01DA021525"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R25-DA037756"],"award-info":[{"award-number":["R25-DA037756"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DA0251525"],"award-info":[{"award-number":["U01-DA0251525"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SMN\u2013139148"],"award-info":[{"award-number":["SMN\u2013139148"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MSH-141971"],"award-info":[{"award-number":["MSH-141971"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["New Investigator award"],"award-info":[{"award-number":["New Investigator award"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010658","name":"St. Paul's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>While patient-reported treatment dissatisfaction is considered an important factor in determining the success of substance use disorder treatment, the levels of dissatisfaction with opioid agonist therapies (OAT) and its relationship with the risk of fentanyl exposure have not been characterized in the context of the ongoing opioid overdose crisis in the US and Canada. Our primary hypothesis was that OAT dissatisfaction was associated with an increased odds of fentanyl exposure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Our objective was to examine self-reported treatment satisfaction among OAT patients in Vancouver, Canada and the association with fentanyl exposure. Longitudinal data were derived from 804 participants on OAT enrolled in two community-recruited harmonized prospective cohort studies of people who use drugs in Vancouver between 2016 and 2018 via semi-annual interviews and urine drug screens (UDS). We employed multivariable generalized estimating equations to examine the relationship between OAT dissatisfaction and fentanyl exposure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 804 participants (57.0% male), 222 (27.6%) reported being dissatisfied with OAT at baseline and 1070 out of 1930 observations (55.4%) had fentanyl exposure. The distribution of OAT reported in the sample was methadone (n\u2009=\u2009692, 77.7%), buprenorphine-naloxone (n\u2009=\u200982, 9.2%), injectable OAT (i.e., diacetylmorphine or hydromorphone; (n\u2009=\u200965, 7.3%), slow-release oral morphine (n\u2009=\u200944, 4.9%) and other\/study medication (n\u2009=\u20098, 1.0%). In the multivariable analysis, OAT dissatisfaction was positively associated with fentanyl exposure (AOR\u2009=\u20091.34; 95% CI: 1.08\u20131.66).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A substantial proportion of OAT patients in our sample reported dissatisfaction with their OAT, and more than half were exposed to fentanyl. We also found that those who were dissatisfied with their OAT were more likely to be exposed to fentanyl. These findings demonstrate the importance of optimizing OAT satisfaction in the context of the ongoing opioid overdose crisis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-021-00234-w","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T17:03:59Z","timestamp":1619629439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting"],"prefix":"10.1186","volume":"16","author":[{"given":"Lindsay","family":"Mackay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Fairbairn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-J.","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-2928","authenticated-orcid":false,"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"234_CR1","unstructured":"BC Centre for Disease Control. Overdose response indicator report. 2020. www.bccdc.ca."},{"key":"234_CR2","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 1999\u20132018 key findings data from the National Vital Statistics System, Mortality. 2020. https:\/\/www.cdc.gov\/nchs\/products\/index.htm."},{"key":"234_CR3","unstructured":"BC Centre for Disease Control. Prescription history and toxicology findings among people who died of an illicit drug overdose in BC, 2015\u20132017. 2019."},{"key":"234_CR4","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. https:\/\/doi.org\/10.1136\/bmj.j1550.","journal-title":"BMJ"},{"key":"234_CR5","unstructured":"British Columbia Centre on Substance Use and B.C. Ministry of Health. A guideline for the clinical management of opioid use disorder; 2017."},{"issue":"4","key":"234_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/add.13238","volume":"111","author":"Y-I Hser","year":"2016","unstructured":"Hser Y-I, Evans E, Huang D, et al. Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial. Addiction. 2016;111(4):695\u2013705. https:\/\/doi.org\/10.1111\/add.13238.","journal-title":"Addiction"},{"issue":"2","key":"234_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, Mcpheeters JT, Crown WH. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):1\u201312. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20622.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"234_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137\u201345. https:\/\/doi.org\/10.7326\/M17-3107.","journal-title":"Ann Intern Med"},{"key":"234_CR9","unstructured":"BC Centre on Substance Use. Guidance for injectable opioid agonist treatment for opioid use disorder; 2017."},{"issue":"4","key":"234_CR10","first-page":"35","volume":"19","author":"S Alcaraz","year":"2017","unstructured":"Alcaraz S, Trujols J, Si\u00f1ol Llosa N, Duran-Sindreu S, Batlle F, de Los Perez, Cobos J. Exploring predictors of response to methadone maintenance treatment for heroin addiction: the role of patient satisfaction with methadone as a medication. Heroin Addict Relat Clin Probl. 2017;19(4):35\u201340.","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"February","key":"234_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2018.02.018","volume":"187","author":"AE Muller","year":"2018","unstructured":"Muller AE, Bj\u00f8rnestad R, Clausen T. Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications. Drug Alcohol Depend. 2018;187(February):22\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.02.018.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"234_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/JCP.0000000000000463","volume":"36","author":"JP De Los Cobos","year":"2016","unstructured":"De Los Cobos JP, Trujols J, Si\u00f1ol N, Duran-Sindreu S, Batlle F. Satisfaction with methadone among heroin-dependent patients with current substance use disorders during methadone maintenance treatment. J Clin Psychopharmacol. 2016;36(2):157\u201362. https:\/\/doi.org\/10.1097\/JCP.0000000000000463.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"234_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.11.020","volume":"83","author":"SW Villafranca","year":"2006","unstructured":"Villafranca SW, McKellar JD, Trafton JA, Humphreys K. Predictors of retention in methadone programs: a signal detection analysis. Drug Alcohol Depend. 2006;83(3):218\u201324. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.11.020.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"234_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.evalprogplan.2009.12.003","volume":"33","author":"M Perreault","year":"2010","unstructured":"Perreault M, White ND, Fabr\u00e8s \u00c9, Landry M, Anestin AS, Rabouin D. Relationship between perceived improvement and treatment satisfaction among clients of a methadone maintenance program. Eval Program Plann. 2010;33(4):410\u20137. https:\/\/doi.org\/10.1016\/j.evalprogplan.2009.12.003.","journal-title":"Eval Program Plann"},{"issue":"3","key":"234_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/00952991003736371","volume":"36","author":"SM Kelly","year":"2010","unstructured":"Kelly SM, O\u2019Grady KE, Brown BS, Mitchell SG, Schwartz RP. The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse. 2010;36(3):150\u20134. https:\/\/doi.org\/10.3109\/00952991003736371.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"234_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/1359105307088142","volume":"13","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Gerstein DR, Friedmann PD. Patient satisfaction and sustained outcomes of drug abuse treatment. J Health Psychol. 2008;13(3):388\u2013400. https:\/\/doi.org\/10.1177\/1359105307088142.","journal-title":"J Health Psychol"},{"key":"234_CR17","unstructured":"Reist D. Methadone maintenance treatment in British Columbia, 1996\u20132008: analysis and recommendations. Victoria. 2010;(May):1996\u20132008."},{"key":"234_CR18","doi-asserted-by":"publisher","unstructured":"Park DA. World Health Organization client satisfaction evaluation. 2000. doi:https:\/\/doi.org\/10.1300\/j022v08n02_02","DOI":"10.1300\/j022v08n02_02"},{"issue":"6","key":"234_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.280.6.547","volume":"280","author":"SA Strathdee","year":"1998","unstructured":"Strathdee SA, Palepu A, Cornelisse PGA, et al. Barriers to use of free antiretroviral therapy in injection drug users. J Am Med Assoc. 1998;280(6):547\u20139. https:\/\/doi.org\/10.1001\/jama.280.6.547.","journal-title":"J Am Med Assoc"},{"issue":"2","key":"234_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.drugpo.2005.12.007","volume":"17","author":"E Wood","year":"2006","unstructured":"Wood E, Kerr T. What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. Int J Drug Policy. 2006;17(2):55\u201360. https:\/\/doi.org\/10.1016\/j.drugpo.2005.12.007.","journal-title":"Int J Drug Policy"},{"key":"234_CR21","unstructured":"Campbell, Larry Boyd, Neil Culbert L. A thousand dreams. 2009."},{"issue":"3","key":"234_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1213\/00000539-199303000-00030","volume":"76","author":"JH Silverstein","year":"1993","unstructured":"Silverstein JH, Rieders MF, McMullin M, Schulman S, Zahl K. An analysis of the duration of fentanyl and its metabolites in urine and saliva. Anesth Analg. 1993;76(3):618\u201321. https:\/\/doi.org\/10.1213\/00000539-199303000-00030.","journal-title":"Anesth Analg"},{"issue":"5","key":"234_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/ADM.0000000000000145","volume":"9","author":"K Marchand","year":"2015","unstructured":"Marchand K, Palis H, Peng D, et al. The role of gender in factors associated with addiction treatment satisfaction among long-term opioid users. Employ Assist Q. 2015;9(5):391\u20138. https:\/\/doi.org\/10.1097\/ADM.0000000000000145.","journal-title":"Employ Assist Q"},{"key":"234_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2147\/PPA.S164181","volume":"12","author":"S Alcaraz","year":"2018","unstructured":"Alcaraz S, Viladrich C, Trujols J, Si\u00f1ol N, Cobos JP. Heroin-dependent patient satisfaction with methadone as a medication influences satisfaction with basic interventions delivered by staff to implement methadone maintenance treatment. Patient Prefer Adherence. 2018;12:1203\u201311. https:\/\/doi.org\/10.2147\/PPA.S164181.","journal-title":"Patient Prefer Adherence."},{"key":"234_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2014.12.008","volume":"53","author":"Z Aziz","year":"2015","unstructured":"Aziz Z, Ph D, Chong NJ, Sc MM. Journal of substance abuse treatment a satisfaction survey of opioid-dependent patients with methadone maintenance treatment. J Subst Abuse Treat. 2015;53:47\u201351. https:\/\/doi.org\/10.1016\/j.jsat.2014.12.008.","journal-title":"J Subst Abuse Treat"},{"key":"234_CR26","unstructured":"College of Physicians and Surgeons of British Columbia. Updates from the methadone maintenance program. https:\/\/www.cpsbc.ca\/for-physicians\/college-connector\/2013-V01-03\/07. Accessed 10 Oct 2020."},{"key":"234_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2017.03.008","volume":"45","author":"ME Soc\u00edas","year":"2017","unstructured":"Soc\u00edas ME, Wood E, McNeil R, et al. Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: Aan interrupted time series analysis. Int J Drug Policy. 2017;45:1\u20138. https:\/\/doi.org\/10.1016\/j.drugpo.2017.03.008.","journal-title":"Int J Drug Policy"},{"key":"234_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.socscimed.2015.04.008","volume":"133","author":"R McNeil","year":"2015","unstructured":"McNeil R, Kerr T, Anderson S, et al. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: a qualitative study. Soc Sci Med. 2015;133:168\u201376. https:\/\/doi.org\/10.1016\/j.socscimed.2015.04.008.","journal-title":"Soc Sci Med"},{"key":"234_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/ADT.0000000000000112","author":"H Barmada","year":"2017","unstructured":"Barmada H, Patil D, Roberts S, Colon-Rivera H, Chang G. Perceived stigma and satisfaction with care among veterans receiving methadone maintenance treatment: a pilot study. Addict Disord Treat. 2017. https:\/\/doi.org\/10.1097\/ADT.0000000000000112.","journal-title":"Addict Disord Treat."},{"issue":"3","key":"234_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253\u20138. https:\/\/doi.org\/10.1016\/s0376-8716(98)00028-3.","journal-title":"Drug Alcohol Depend"},{"key":"234_CR31","unstructured":"Public Health Agency of Canada. Special Advisory Committee on the Epidemic of Opioid Overdoses. National Report: Opioid-Related Harms in Canada Web-Based Report. Ottawa; 2019."}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-021-00234-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-021-00234-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-021-00234-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T17:13:59Z","timestamp":1619630039000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-021-00234-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1186\/s13722-021-00234-w","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"21 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"University of British Columbia and Providence Health Care Research Ethics Board provided ethical approval. All participants provided informed consent prior to cohort study enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no relevant disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}